Reactions Weekly

, Volume 1695, Issue 1, pp 263–263 | Cite as

Multiple drugs

Febrile neutropenia: case report
Case report


  1. Dakdouki YEL, et al. Dose-adjusted rituximab mini-CYVE (CYtarabine bolus, VEpeside and dexamethasone) for patients with relapsed or refractory B-cell non-hodgkin lymphoma not eligible for high dose therapy. Blood 130 (Suppl. 1): Dec 2017 [abstract] - FranceGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations